To get approval for clinical trials in China, submit an application to the National Medical Products Administration (NMPA), including preclinical data and trial protocols. The NMPA reviews for safety and efficacy. Ethical approval from an Institutional Review Board (IRB) is also required. Approval typically takes several months.